Treatment of Melanoma Cells with Chloroquine and Everolimus Activates the Apoptosis Process and Alters Lipid Redistribution
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212278 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dorota Ciołczyk-Wierzbicka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Medical Biochemistry, Jagiellonian University Medical College, ul. Kopernika 7, 31-034 Cracow, Poland. Hauptthemen laut MEDLINE: Chloroquine, Apoptosis, Melanoma, Everolimus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by a grant from the Ministry of Science and Higher Education through Jagiellonian University Medical College, Ministry of Science and Higher Education through Jagiellonian University Medical College.
Abstract (Originalsprache)
The balance between apoptosis and autophagy plays a key role in cancer biology and treatment strategies. The aim of this study was to assess the effect of the mTOR kinase inhibitor everolimus and chloroquine on the regulation of proliferation, caspase-3 activation, and apoptosis in melanoma cells. We studied the activity of caspase-3 and the levels of caspase-3 and -9 using the Western blot technique. Cellular apoptosis was examined using a DNA fragmentation assay, and changes in the cell nucleus and cytoskeleton were examined using fluorescence microscopy DAPI, OA/IP. We also studied the rearrangement of lipid structures using fluorescent dyes: Nile Red and Nile Blue. A low nanomolar concentration of the mTOR kinase inhibitor everolimus in combination with chloroquine activated the apoptosis process and decreased cell proliferation. These changes were accompanied by an obvious change in cell morphology and rearrangement of lipid structures. Alterations in lipid redistribution accompanying the process of apoptosis and autophagy are among the first to occur in the cell and can be easily monitored in in vitro studies. The combination of mTOR inhibitors and chloroquine represents a promising area of research in cancer therapy. It has the potential to enhance treatment efficacy through complementary mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Medical Biochemistry, Jagiellonian University Medical College, ul. Kopernika 7, 31-034 Cracow, Poland.
- Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University, John Paul II Hospital, ul. Pra˛dnicka 80, 31-202 Cracow, Poland.
ORCID-Profile: Dorota Ciołczyk-Wierzbicka, Marta Zarzycka, Grzegorz Zemanek
Förderung
- This work was supported by a grant from the Ministry of Science and Higher Education through Jagiellonian University Medical College
- Ministry of Science and Higher Education through Jagiellonian University Medical College
Zitieren
APA
Ciołczyk-Wierzbicka, D., Zarzycka, M., Placha, W., Zemanek, G., & Wierzbicki, K. (2024). Treatment of Melanoma Cells with Chloroquine and Everolimus Activates the Apoptosis Process and Alters Lipid Redistribution. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212278
Vancouver
Ciołczyk-Wierzbicka D, Zarzycka M, Placha W, Zemanek G, Wierzbicki K. Treatment of Melanoma Cells with Chloroquine and Everolimus Activates the Apoptosis Process and Alters Lipid Redistribution. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212278
BibTeX
@article{CioczykWierzbicka2024,
author = {Ciołczyk-Wierzbicka, Dorota and Zarzycka, Marta and Placha, Wojciech and Zemanek, Grzegorz and Wierzbicki, Karol},
title = {Treatment of Melanoma Cells with Chloroquine and Everolimus Activates the Apoptosis Process and Alters Lipid Redistribution},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212278}
}
EUVIMED